Temporomandibular Joint Disc Displacement, With Reduction
6
2
2
4
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 6 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (6)
Comparative Assessment of Arthrocentesis Methods in TMJ Disorders
Long-term Follow up of TMJ Surgery and Evaluation of the 6-month Control as a Prognostic Marker.
Does Successive Intra-articular Injections of Tenoxicam or Meloxicam Affect Treatment of TMJ Displacement
TMJ Arthroscopic Lysis and Lavage Compared to Operative Arthroscopy in Disc Displacement With Reduction.
Evolving Treatment Modalities for Management of Patients Suffering From Disc Displacement With Reduction
Can Extracorporeal Shock Wave Therapy Be Effective in Temporomandibular Joint Disease